Navigation Links
Ikaria Introduces Dr. Michael Cooreman as Vice President of Translational Medicine
Date:6/24/2008

r understand a compound's likely safety and efficacy to promote faster drug development. In addition, because it estimates a compound's likelihood to succeed in late stage clinical development, it facilitates earlier, more reliable decisions on whether or not to proceed with development, thus freeing up R&D resources to pursue more promising pathways. We believe that the establishment of a Translational Medicine department is a significant step towards expanding our capabilities in the development of therapies for critically ill patients and look forward to seeing Michael's work in this important and growing area of clinical trial design."

Dr. Cooreman most recently served as a Senior Translational Medicine Expert, Autoimmune Diseases and Transplantation, Exploratory Clinical Development at Novartis. Prior to joining Novartis in 2003, Michael spent almost ten years in academic medicine, with appointments including Associate Professor of Medicine and Staff Gastroenterologist at the University of Amsterdam in The Netherlands and as Visiting Scientist at Mt. Sinai School of Medicine, Department of Liver Diseases, in New York City. Earlier in his career, he spent two years as Head of Clinical Research and Development, Gastroenterology and Oncology at Janssen Pharmaceuticals in Germany. Michael received certification in Germany in Internal Medicine, Gastroenterology and Hepatology, earned an M.D. at the University of Leuven Medical School, Belgium, and a doctorate at the University of Dusseldorf, Germany.

About Ikaria Holdings, Inc.

Ikaria Holdings, Inc. is a fully integrated biotherapeutics company focused on the development and commercialization of innovative pharmaceutical and biological products and drug/device combinations for the critically ill in the hospital and ICU setting. The company's product, INOmax(R) (nitric oxide) for inhalation, is an FDA-approved drug for the treatment of hypoxic respiratory failure in term and near-term newborns. T
'/>"/>

SOURCE Ikaria Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. New Study Shows Promise for Hydrogen Sulfide in Reducing Heart-Attack Damage, Ikaria Announces
2. Ikaria Founding Scientist Named 2007 MacArthur Fellow
3. Ikaria to Present at 26th Annual JPMorgan Healthcare Conference
4. Ikaria Appoints Daniel Tasse as President and Chief Executive Officer
5. Lota Zoth Elected to Ikaria Board and Named Audit Committee Chair
6. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
7. Caliper Life Sciences Introduces High Throughput RNA Assay to Improve Workflow in Gene Expression Studies
8. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
9. Small Bone Innovations Introduces New Distal Radius Plating System to Repair Complex Fractures
10. Advanced Instruments Introduces Worlds Fastest High Throughput Freezing Point Osmometer
11. Harmonex Introduces CliniCom(TM), a Breakthrough in Psychiatric Intake and Assessment Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2015)... ... 26, 2015 , ... Lee Biosolutions, a global biotech healthcare ... of highly valued cardiac markers used in early detection of heart disease due ... has led to the development and commercialization of important cardiac biomarkers used in ...
(Date:8/26/2015)... 2015 China Cord Blood Corporation (NYSE: ... leading provider of cord blood collection, laboratory testing, hematopoietic ... announced that the Company has been informed that Magnum ... owned by Mr. Yuen Kam, chairman of the board ... shares (the "Shares") of  Excellent China Healthcare Investment Limited ...
(Date:8/25/2015)... , Aug. 25, 2015   WuXi PharmaTech (Cayman) ... capability and technology platform company serving the pharmaceutical, biotechnology, ... ("Lee,s Pharm," Hong Kong Exchange Stock Code: 0950), a ... with 20 years of operations in ... companies have signed an agreement whereby WuXi,s Laboratory Testing ...
(Date:8/25/2015)... San Diego, CA (PRWEB) , ... ... ... Corporation®, a premier developer of build-to-order, independent blade-based and rackmount computing infrastructure, ... high performance workstation rackmount offering, the RM1630DX. The latest system boasts two ...
Breaking Biology Technology:Lee Biosolutions Announces Increased Investment in the Development and Manufacturing of Biomarkers Used in Early Detection Of Heart Disease 2China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 2China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 3WuXi PharmaTech to Be Exclusive Supplier of Laboratory Testing Services to Lee's Pharm 2WuXi PharmaTech to Be Exclusive Supplier of Laboratory Testing Services to Lee's Pharm 3Cirrascale® Announces Next Generation High Density, Two-in-One GPU Rackmount Offering Perfect for High Performance Remote Workstations 2Cirrascale® Announces Next Generation High Density, Two-in-One GPU Rackmount Offering Perfect for High Performance Remote Workstations 3
... 17, 2010 ... if (typeof(lpUnit)==,undefined,) var ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s ... one. for (var r in data.results) { first_result = data.results[r]; break; } for (var key in first_result) ...
... DIEGO, Aug. 17 Imagenetix, Inc. (OTC Bulletin Board: ... 30, 2010. Net sales decreased 36% for the first quarter of ... of last year.   Net loss for the first quarter was ... or $.04 per share for the same period of the prior ...
... announced today that it has initiated a phase 2 ... the treatment of PHN. XEN402 has ... and recently concluded a 21-day cumulative dose safety tolerability ... was well tolerated and achieved good drug concentrations in ...
Cached Biology Technology:Shire plc - Statement re ProAmatine 2Shire plc - Statement re ProAmatine 3Shire plc - Statement re ProAmatine 4Shire plc - Statement re ProAmatine 5Shire plc - Statement re ProAmatine 6Imagenetix, Inc. Reports First Quarter 2011 Results 2Imagenetix, Inc. Reports First Quarter 2011 Results 3Xenon Pharmaceuticals Initiates a Phase 2 Clinical Trial in Post Herpetic Neuralgia (PHN) for Topical XEN402. 2
(Date:8/10/2015)... , August 10, 2015 The latest ... offers comprehensive analysis of the global border security market ... revenues of $16.4bn in 2015. Now: Border security ... an example of the business critical issue you need to ... visiongain ,s objective analysis of how this will impact ...
(Date:8/6/2015)... and TELTOW, Germany , ... 2015 Siggraph Conference, SensoMotoric Instruments (SMI) shows ... reality , based on Epson,s Moverio BT-200 ... tracking platform. With this new solution, unprecedented quality and ... hands-free interaction with context-sensitive displays. For the first time, ...
(Date:8/5/2015)... , August 5, 2015 ... & Access Management Market by Software, Services, Vertical (BFSI, Airport, ... & Geography - Global Forecast to 2020", published by ... Management Market globally into various segments. The global PIAM ... 2014 to $546.2 Million by 2019, at a CAGR ...
Breaking Biology News(10 mins):Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 2Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 3Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 4Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 5Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 6Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 7Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 8Border Security Market Report 2015-2025 - Growth in Biometrics, ICT, Manned and Unmanned Vehicles, and Perimeter Surveillance 9SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 2Physical Identity and Access Management Market Worth $546.2 Million by 2019 3Physical Identity and Access Management Market Worth $546.2 Million by 2019 4
... Cold Spring Harbor, N.Y. Cancer cells grow fast. That,s ... crashed through all the cell-cycle checkpoints and are continuously growing ... they need to speed up their metabolism. CSHL ... to target the cancer cell metabolic process and in the ...
... reduce hot flashes and associated symptoms among postmenopausal ... at Baylor University,s Mind-Body Medicine Research Laboratory. , Hypnotic ... 80 percent, and the findings also showed participants experienced ... and depression. , The mind-body therapy study of 187 ...
... Liverpool have found that, like humans, obese dogs can ... issues that occur in the body at the same ... number of health problems, such as increased blood glucose ... to increase the risk of other diseases, such as ...
Cached Biology News:Team uses antisense technology that exploits gene splicing mechanism to kill cancer cells 2Team uses antisense technology that exploits gene splicing mechanism to kill cancer cells 3Clinical hypnosis can reduce hot flashes after menopause, Baylor study shows 2Obese dogs at risk of health condition experienced by humans 2
Glutathione Agarose Beads 10 ml...
Anti-Ephrin B1 Host: rabbit polyclonal Species Reactivity: human Applications: WB Storage: 4C...
Rabbit monoclonal [EP881Y] to EEF2K ( Abpromise for all tested applications). Antigen: Synthetic peptide corresponding to residues in the C-terminal of human EEF2K. Entrez GeneID: 29904 S...
...
Biology Products: